Nuformix, Open Orphan, Zoetic International and Live Company Group
Episode 1649, Nov 25, 2019, 01:24 PM
Nuformix discuss their placing and operational progress. Open Orphan talk about the early adopters signed up to their Genomic Health DataBANK. Zoetic International provides an update on its operations and current trading. Live Company Group on the deferred consideration on their purchase of Bright Bricks.
On the Vox Markets Podcast Today: 25th November 2019
Dr Dan Gooding, Chief Executive Officer of Nuformix #NFX discusses how their placing will allow the Group to strengthen its overall position during negotiations and accelerate progress.
Maurice Treacy, Chief Commercial Officer of Open Orphan #ORPH reveals they have signed five pharmaceutical and biotechnology companies as early adopters of its Genomic Health DataBANK platform.
(Interview starts at 10 minutes 4 seconds)
Nick Tulloch, CEO of Zoetic International #ZOE provides an update on its operations and current trading including six new CBD products to be launched in the UK ahead of Christmas.
(Interview starts at 20 minutes 7 seconds)
David Ciclitira, Chairman, Live Company Group #LVCG provides a further update on the deferred consideration on their purchase of Bright Bricks which they acquired in October 2018.
(Interview starts at 28 minutes 52 seconds)
Plus the Top 5 Most Followed Companies & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours.
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast